Epitel, Inc.

Epitel, Inc.Epitel, Inc.
Epitel, Inc.

Epitel, Inc.

Epitel develops AI-driven wireless brain health technologies for remote EEG monitoring, improving diagnosis and management of neurological conditions like epilepsy.

Website
DR 412017ActiveSalt Lake City, United States
Rate
Advertise here

About

Epitel is a digital health company that modernizes brain health solutions through its proprietary cloud-based wearable sensor system and innovative AI technologies. Their flagship product, the REMI® Remote EEG Monitoring System, provides accessible, affordable, and reliable electrographic seizure detection, empowering better treatment decisions for patients and healthcare professionals in both hospital and ambulatory settings.
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Epitel, Inc. do?

Epitel is a digital health company that modernizes brain health solutions through its proprietary cloud-based wearable sensor system and innovative AI technologies. Their flagship product, the REMI® Remote EEG Monitoring System, provides accessible, affordable, and reliable electrographic seizure detection, empowering better treatment decisions for patients and healthcare professionals in both hospital and ambulatory settings.

How much funding has Epitel, Inc. raised?

Epitel, Inc. has raised a total of $26M in funding. The most recent round on record is Series B.

Where is Epitel, Inc. headquartered?

Epitel, Inc. is headquartered in Salt Lake City, United States.

When was Epitel, Inc. founded?

Epitel, Inc. was founded in 2017.

What industry does Epitel, Inc. operate in?

Epitel, Inc. operates in HealthTech, Medical Devices, Artificial Intelligence, Biotechnology, MedTech, Digital Health.

What is Epitel, Inc.'s revenue?

StartupHub estimates Epitel, Inc.'s annual revenue at $11.5M (range $6.0M to $25.0M, 29% confidence), based on comparable companies in the sector.

What is Epitel, Inc.'s valuation?

StartupHub estimates Epitel, Inc.'s effective valuation at $1.1B (range $760.8M to $1.4B, 41% confidence), based on comparable companies in the sector.